Andelyn and PQP Group Partner to Simplify Cell and Gene Therapy Supply Across Europe

Expanding cell and gene therapy trials into Europe presents challenges in regulatory compliance, import procedures, product handling and clinical supply. A...

November 19, 2026 | Thursday | Interaction
AAVantgarde Advances Dual-AAV Gene Therapies for Usher Syndrome and Stargardt Disease

Inherited retinal diseases such as Usher syndrome and Stargardt disease remain difficult to treat, particularly when the genes involved are too large for c...

November 17, 2026 | Tuesday | Interaction
Quotient Sciences Advances AI-Guided Drug Formulation to Shorten Clinical Development

Developing effective drug formulations remains a major challenge for biopharma companies, particularly for molecules with poor solubility or complex releas...

November 16, 2026 | Monday | Interaction
MRM Health and Biocodex Advance €15 Million Manufacturing Partnership for Microbiome-Based Medicines

Bringing microbiome-based therapies to patients requires more than promising clinical results. Manufacturing complex mixtures of live bacteria consistently...

November 13, 2026 | Friday | Interaction
Pharvaris Reports Positive Phase 3 Results for Oral Deucrictibant in Hereditary Angioedema

For people living with hereditary angioedema (HAE), sudden and unpredictable swelling attacks can disrupt daily life and require urgent treatment. Pharva...

November 12, 2026 | Thursday | News
InnoCare Advances Dual-Target Antibody ICP-B161 for Inflammatory Bowel Disease Treatment

For patients living with inflammatory bowel disease (IBD), persistent symptoms, repeated treatment failures and the need for lifelong therapy remain major ...

November 11, 2026 | Wednesday | Interaction
Idorsia Advances Oral Fabry Disease Treatment Lucerastat into Phase 3 Clinical Development

For patients living with Fabry disease, progressive kidney damage can lead to dialysis, transplantation and serious long-term complications. Idorsia is dev...

November 10, 2026 | Tuesday | Interaction
SOTERIA’s CANCER HUNT Programme Expands Free Precision Cancer Care for US Veterans and Military Personnel

For military personnel and veterans diagnosed with cancer, accessing specialised testing and treatment options can be difficult, particularly when care...

November 09, 2026 | Monday | Interview
Gesynta Pharma Advances Non-Hormonal Endometriosis Treatment Vipoglanstat Following Early Phase 2 Trial Enrolment

For millions of women living with endometriosis, persistent pain can disrupt daily life, affect fertility and limit treatment choices. Existing hormonal th...

November 05, 2026 | Thursday | Interaction
Ambrose Healthcare’s Rare Disease Strategy: Reviving Promising Therapies Through Strategic Acquisitions

Ambrose Healthcare’s acquisition of AM-Pharma, valued at up to €161 million plus royalties, strengthens its rare disease pipeline and establishe...

November 04, 2026 | Wednesday | Interview
Salvia Advances MySalvia Implantable Migraine Therapy with Pivotal RECLAIM-II Trial in the US

Biopharma Boardroom speaks with Hubert Martens, CEO of Salvia BioElectronics, about the development of the MySalvia System, an investigational implantable ...

November 02, 2026 | Monday | Interaction
Axplora Advances Axotecan Development to Strengthen European Exatecan Supply for ADC Manufacturers

As demand for Exatecan-based antibody-drug conjugates (ADCs) grows, securing reliable manufacturing capacity and diversified supply chains has become a pri...

October 30, 2026 | Friday | Interaction
Advanced Clinical Appoints John Cargill as Chief Commercial Officer to Drive Global Growth

Advanced Clinical, a global clinical research organization (CRO) providing full-service clinical development, functional service provider (FSP) solutions a...

October 23, 2026 | Friday | News
Lundbeck Advances Lu AF28996 into Phase II Trial for Advanced Parkinson’s Disease

Managing motor fluctuations and dyskinesia remains a significant challenge for people living with advanced Parkinson's disease, despite advances in existin...

October 20, 2026 | Tuesday | Interview

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close